| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.086 | 0.008 |
| mRNA | tubastatin A | GDSC1000 | pan-cancer | AAC | 0.083 | 0.008 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | -0.13 | 0.009 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | 0.14 | 0.009 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.11 | 0.01 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.01 |
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.01 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | 0.092 | 0.01 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | -0.08 | 0.01 |
| mRNA | BIX02189 | GDSC1000 | pan-cancer | AAC | 0.081 | 0.01 |